{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:15:22Z","timestamp":1788401722116,"version":"build-2803163510"},"reference-count":45,"publisher":"American Chemical Society (ACS)","issue":"2","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccbyncnd_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["722717"],"award-info":[{"award-number":["722717"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["799880"],"award-info":[{"award-number":["799880"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["233114"],"award-info":[{"award-number":["233114"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Doctoral Programme in Drug Research, University of Eastern Finland","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Russian Government","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The mechanisms of drug clearance from the aqueous humor are poorly defined. In this study, a cocktail approach was used to simultaneously determine the pharmacokinetics of three \u03b2-blocker agents after intracameral (ic) injection into the rabbit eyes. Aqueous humor samples were collected and analyzed using LC\u2013MS\/MS to determine drug concentrations. Pharmacokinetic parameters were obtained using a compartmental fitting approach, and the estimated clearance, volume of distribution, and half-life values were the following: atenolol (6.44 \u03bcL\/min, 687 \u03bcL, and 73.87 min), timolol (19.30 \u03bcL\/min, 937 \u03bcL, and 33.64 min), and betaxolol (32.20 \u03bcL\/min, 1421 \u03bcL, and 30.58 min). Increased compound lipophilicity (atenolol &amp;lt; timolol &amp;lt; betaxolol) resulted in higher clearance and volume of distributions in the aqueous humor. Clearance of timolol and betaxolol is about 10 times higher than the aqueous humor outflow, demonstrating the importance of other elimination routes (e.g., uptake to iris and ciliary body and subsequent elimination via blood flow).<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.9b01024","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T17:15:21Z","timestamp":1575393321000},"page":"588-594","source":"Crossref","is-referenced-by-count":4,"title":["Ocular\nIntracameral Pharmacokinetics for a Cocktail\nof Timolol, Betaxolol, and Atenolol in Rabbits"],"prefix":"10.1021","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9207-8259","authenticated-orcid":true,"given":"Anam","family":"Fayyaz","sequence":"first","affiliation":[{"name":"Certara UK, Simcyp Division , Level 2-Acero, 1 Concourse Way , ,","place":["Sheffield, U.K., S1 2BJ"]},{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Ranta","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Toropainen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati-Sisko","family":"Vellonen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe D\u2019Amico","family":"Ricci","sequence":"additional","affiliation":[{"name":"University of Sassari , , ,","place":["Sassari, Italy"]},{"name":"Asl Citta\u0300 di Torino, Ospedale Oftalmico di Torino , U.O.C Oculistica 2, Ospedale San Giovanni Bosco di Torino , ,","place":["Torino, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Reinisalo","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]},{"name":"University of Eastern Finland , , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5923-7289","authenticated-orcid":true,"given":"Emma M.","family":"Heikkinen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Gardner","sequence":"additional","affiliation":[{"name":"Certara UK, Simcyp Division , Level 2-Acero, 1 Concourse Way , ,","place":["Sheffield, U.K., S1 2BJ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 1 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-0194","authenticated-orcid":true,"given":"Masoud","family":"Jamei","sequence":"additional","affiliation":[{"name":"Certara UK, Simcyp Division , Level 2-Acero, 1 Concourse Way , ,","place":["Sheffield, U.K., S1 2BJ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"del Amo","sequence":"additional","affiliation":[{"name":"University of Manchester , , Oxford Road , ,","place":["Manchester, U.K., M13 9PL"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"issue":"1","key":"2026090221481527800_cit1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2302\/kjm.10.15","article-title":"Aqueous humor\npH measurement in vivo of the use of a closed system technique with\nglass capillary electrode","volume":"10","author":"Sakanoue","year":"1961","journal-title":"Keio J. Med."},{"issue":"5","key":"2026090221481527800_cit2","first-page":"291","article-title":"The pH reaction\nin aqueous humor to antiglaucoma agents of various concentrations\nand pH levels","volume":"57","author":"Veselovsky\u0301","year":"2001","journal-title":"Cesk. Slov. Oftalmol."},{"issue":"7","key":"2026090221481527800_cit3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/02713689808951246","article-title":"Ocular\nhypotensive and vasodilative\neffects of two \u03b2-adrenergic blockers with intrinsic sympathomimetic\nactivity","volume":"17","author":"Hong","year":"1998","journal-title":"Curr. Eye Res."},{"issue":"1","key":"2026090221481527800_cit4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)22303-5","article-title":"Stereospecificity\nof beta adrenergic antagonists: R-enantiomers show increased selectivity\nfor beta-2 receptors in ciliary process","volume":"245","author":"Nathanson","year":"1988","journal-title":"J.\nPharmacol. Exp. Ther."},{"issue":"3","key":"2026090221481527800_cit5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.exer.2003.11.001","article-title":"Studies on the mechanism of action\nof timolol and on the effects of suppression and redirection of aqueous\nflow on outflow facility","volume":"78","author":"Kiland","year":"2004","journal-title":"Exp. Eye Res."},{"issue":"6","key":"2026090221481527800_cit6","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1161\/01.RES.66.6.1610","article-title":"Selective beta 1-adrenoceptor blockade\nenhances positive inotropic responses to endogenous catecholamines\nmediated through beta 2-adrenoceptors in human atrial myocardium","volume":"66","author":"Hall","year":"1990","journal-title":"Circ. Res."},{"issue":"2","key":"2026090221481527800_cit7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1007784109255","article-title":"Beta-blocker selectivity\nat cloned human beta1-and\nbeta2-adrenergic receptors","volume":"13","author":"Smith","year":"1999","journal-title":"Cardiovasc. Drugs\nTher."},{"issue":"6","key":"2026090221481527800_cit8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3109\/10641968409039587","article-title":"The effect of a non-selective lipophilic\nbeta-blocker on the blood pressure and noradrenaline, vasopressin,\ncortisol and renin release during alcohol withdrawal","volume":"6","author":"Potter","year":"1984","journal-title":"Clin. Exp. Hypertens., Part A"},{"key":"2026090221481527800_cit9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/OPTH.S91286","article-title":"Pharmacokinetics\nand aqueous humor penetration of levofloxacin 1.5% and moxifloxacin\n0.5% in patients undergoing cataract surgery","volume":"10","author":"Bucci","year":"2016","journal-title":"Clin. Ophthalmol."},{"issue":"6","key":"2026090221481527800_cit10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7150\/ijms.11376","article-title":"Comparison of drug\nconcentrations in human aqueous humor after the administration of\n0.3% gatifloxacin ophthalmic gel, 0.3% gatifloxacin and 0.5% levofloxacin\nophthalmic solutions","volume":"12","author":"Ding","year":"2015","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"2026090221481527800_cit11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jps.2600660222","article-title":"Aqueous chamber\ndrug distribution volume measurement\nin rabbits.inson, J. R. Aqueous chamber drug distribution volume measurement\nin rabbits","volume":"66","author":"Conrad","year":"1977","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"2026090221481527800_cit12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0378-5173(82)90051-5","article-title":"Disposition of pilocarpine\nin the pigmented rabbit\neye","volume":"11","author":"Lee","year":"1982","journal-title":"Int. J. Pharm."},{"issue":"3","key":"2026090221481527800_cit13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00004397-198002030-00004","article-title":"Structures\nand fluids involved in the penetration of topically applied drugs","volume":"20","author":"Maurice","year":"1980","journal-title":"International ophthalmology clinics"},{"issue":"2","key":"2026090221481527800_cit14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/eye.1997.43","article-title":"The uveoscleral\noutflow routes","volume":"11","author":"Nilsson","year":"1997","journal-title":"Eye"},{"key":"2026090221481527800_cit15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-540-69469-4_2","article-title":"Determination\nof ocular blood flows with the microsphere method","volume-title":"Ocular Blood Flow","author":"Nilsson","year":"2012"},{"issue":"3","key":"2026090221481527800_cit16","first-page":"332","article-title":"Permeability of the intraocular blood\nvessels","volume":"100","author":"Bill","year":"1980","journal-title":"Trans. Ophthalmol. Soc. U.K."},{"issue":"2","key":"2026090221481527800_cit17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0014-4835(78)90086-6","article-title":"The fate of anterior chamber fluorescein\nin the monkey eye 1. the anterior chamber outflow pathways","volume":"27","author":"Sherman","year":"1978","journal-title":"Exp. Eye Res."},{"key":"2026090221481527800_cit18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1201\/9780203912072.ch3","article-title":"General considerations\nin ocular drug delivery","volume-title":"Ophthalmic Drug\nDelivery Systems","author":"Chastain","year":"2003"},{"key":"2026090221481527800_cit19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal\nclearance and volume of distribution of compounds in rabbits: In silico\nprediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"2026090221481527800_cit20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0002-9394(14)78372-2","article-title":"The rate of\nflow of aqueous humor: II. Derivation of\nrate of flow and its physiologic significance","volume":"32","author":"Kinsey","year":"1949","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"2026090221481527800_cit21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following\ntopical\ndelivery","volume":"16","author":"Ja\u0308rvinen","year":"1995","journal-title":"Adv. Drug Delivery Rev."},{"issue":"2","key":"2026090221481527800_cit22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejpb.2005.01.009","article-title":"Cell culture models of the ocular\nbarriers","volume":"60","author":"Hornof","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2026090221481527800_cit23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1201\/9780203912072.ch5","article-title":"Ocular pharmacokinetics and pharmacodynamics","volume-title":"Ophthalmic Drug Delivery Systems","author":"Schoenwald","year":"2003"},{"issue":"5","key":"2026090221481527800_cit24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jps.2600690544","article-title":"Pilocarpine\nocular distribution volume","volume":"69","author":"Miller","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"2026090221481527800_cit25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retinal Eye Res."},{"key":"2026090221481527800_cit26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-69222-2_2","article-title":"Ocular Pharmacokinetics","volume-title":"Pharmacology\nof the Eye","author":"Maurice","year":"1984"},{"issue":"10","key":"2026090221481527800_cit27","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1023\/A:1018964823193","article-title":"Characterization\nof ocular pharmacokinetics\nof beta-blockers using a diffusion model after instillation","volume":"16","author":"Yamamura","year":"1999","journal-title":"Pharm. Res."},{"key":"2026090221481527800_cit28","first-page":"121","article-title":"Animal\npharmacokinetic\nstudies","volume-title":"Ophthalmic Drug Delivery Systems","author":"Urtti","year":"1993"},{"issue":"4","key":"2026090221481527800_cit29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2165\/00003088-199018040-00001","article-title":"Ocular\ndrug delivery. Pharmacokinetic considerations","volume":"18","author":"Schoenwald","year":"1990","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"2026090221481527800_cit30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0974-9233.124084","article-title":"Clear corneal incision\nin cataract surgery","volume":"21","author":"Al Mahmood","year":"2014","journal-title":"Middle East African journal\nof ophthalmology"},{"issue":"4","key":"2026090221481527800_cit31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/jop.1995.11.489","article-title":"Comparison of concentration-time\nprofiles of levobunolol\nand timolol in anterior and posterior ocular tissues of albino rabbits","volume":"11","author":"Acheampong","year":"1995","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"1","key":"2026090221481527800_cit32","first-page":"105","article-title":"Optimizing the systemic and ocular\nabsorption of timolol from eye-drops","volume":"2","author":"Ja\u0308rvinen","year":"1992","journal-title":"STP Pharma\nSci."},{"issue":"3","key":"2026090221481527800_cit33","first-page":"248","article-title":"Beta-adrenergic blockers: ocular penetration and binding\nto the uveal pigment","volume":"26","author":"Araie","year":"1982","journal-title":"Jpn. J. Ophthalmol."},{"issue":"11","key":"2026090221481527800_cit34","first-page":"2948","article-title":"Pharmacokinetic\nbasis for nonadditivity\nof intraocular pressure lowering in timolol combinations","volume":"32","author":"Lee","year":"1991","journal-title":"Invest. Ophthalmol. Visual Sci."},{"issue":"1","key":"2026090221481527800_cit35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1755-3768.1987.tb08493.x","article-title":"The pharmacokinetics\nof ocularly applied timolol in rabbits","volume":"65","author":"Huupponen","year":"1987","journal-title":"Acta\nOphthalmol."},{"issue":"1","key":"2026090221481527800_cit36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0014-4835(89)90025-0","article-title":"Protein\ncomposition of human aqueous\nhumor: SDS-PAGE analysis of surgical and post-mortem samples","volume":"48","author":"Tripathi","year":"1989","journal-title":"Exp. Eye Res."},{"issue":"3","key":"2026090221481527800_cit37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0378-5173(90)90215-P","article-title":"Controlled drug delivery\ndevices for experimental ocular studies\nwith timolol 2. Ocular and systemic absorption in rabbits","volume":"61","author":"Urtti","year":"1990","journal-title":"Int. J. Pharm."},{"issue":"2","key":"2026090221481527800_cit38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-4835(84)90104-0","article-title":"Disposition of ophthalmic\ntimolol in treated and untreated rabbit\neyes. A multiple and single dose study","volume":"38","author":"Salminen","year":"1984","journal-title":"Exp.\nEye Res."},{"issue":"9","key":"2026090221481527800_cit39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1023\/A:1015923514012","article-title":"The kinetics\nof\ntimolol in the rabbit lens: implications for ocular drug delivery","volume":"6","author":"Ahmed","year":"1989","journal-title":"Pharm. Res."},{"issue":"3","key":"2026090221481527800_cit40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/exer.1993.1133","article-title":"Systemic absorption pathways of topically\napplied beta adrenergic antagonists in the pigmented rabbit","volume":"57","author":"Lee","year":"1993","journal-title":"Exp. Eye Res."},{"issue":"6","key":"2026090221481527800_cit41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/BF01059556","article-title":"Ocular and\nsystemic bioavailability of ophthalmic flurbiprofen","volume":"12","author":"Tang-Liu","year":"1984","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"8","key":"2026090221481527800_cit42","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1167\/iovs.09-4694","article-title":"Experimental intracameral\ninjection of vancomycin microparticles in rabbits","volume":"51","author":"Kodjikian","year":"2010","journal-title":"Invest. Ophthalmol. Visual Sci."},{"issue":"5","key":"2026090221481527800_cit43","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1128\/AAC.01125-08","article-title":"Pharmacokinetics\nof intracameral\nvoriconazole injection","volume":"53","author":"Shen","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"2026090221481527800_cit44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jps.2600760405","article-title":"Ocular bioavailability and tissue distribution of [14C]\nketorolac tromethamine in rabbits","volume":"76","author":"Ling","year":"1987","journal-title":"J. Pharm.\nSci."},{"issue":"1","key":"2026090221481527800_cit45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0378-5173(84)90132-7","article-title":"Effect of\nocular pigmentation on pilocarpine pharmacology in the rabbit eye.\nII. Drug response","volume":"19","author":"Urtti","year":"1984","journal-title":"Int. J. Pharm."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.9b01024","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/2\/588\/67091493\/acs.molpharmaceut.9b01024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/2\/588\/67091493\/acs.molpharmaceut.9b01024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:50:01Z","timestamp":1788400201000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/17\/2\/588\/1445850\/Ocular-Intracameral-Pharmacokinetics-for-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,12,3]]},"published-print":{"date-parts":[[2020,2,3]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b01024","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}